Tramadol in Breastfeeding
Tramadol can be used with caution during breastfeeding, but should be restricted to inpatient use only, limited to the lowest effective dose for the shortest duration possible, with close monitoring of the infant for respiratory depression, excessive sedation, and decreased alertness. 1
Key Safety Considerations
The evidence presents a nuanced picture with conflicting regulatory guidance:
- FDA Warning (2017): Issued a statement warning against tramadol use while breastfeeding due to case reports of respiratory depression and death in infants 1, 2
- UK Position: Despite the FDA warning, UK Drug Information and Lactation Advisory Service (UKDILAS) recommends tramadol can continue to be used with caution during breastfeeding 1
Pharmacokinetic Data
Research demonstrates that tramadol and its active metabolite O-desmethyltramadol are excreted into breast milk at relatively low levels:
- Relative infant dose: <3% of maternal dose 2, 3
- Milk-to-plasma ratio: 2.2 for tramadol and 2.8 for O-desmethyltramadol 3
- Estimated absolute infant dose: 112 μg/kg/day for tramadol and 30 μg/kg/day for O-desmethyltramadol 3
However, one case study documented significantly higher breast milk concentrations (1,254 ng/mL tramadol on day 20 postpartum) with detectable levels in neonatal oral fluid 4, highlighting individual variability.
Clinical Algorithm for Use
If tramadol must be used:
Setting: Restrict to inpatient use only where both mother and infant can be monitored 1
Dosing: Use the lowest effective dose for the shortest time possible 1
Infant Monitoring (mandatory):
Maternal Monitoring: Watch for maternal excess effects, which may predict infant risk 1
Safer Alternative Analgesics
Preferred options for postpartum pain in breastfeeding mothers include:
- First-line: Paracetamol and NSAIDs (ibuprofen, diclofenac, naproxen) - all considered safe 1
- If stronger analgesia needed: Morphine is recommended as the opioid of choice 1
- Weak opioid alternative: Dihydrocodeine may be preferred over tramadol due to cleaner metabolism and more predictable effects 1
Critical Pitfalls to Avoid
Outpatient prescribing: Do not prescribe tramadol for home use in breastfeeding mothers - the guideline explicitly states restriction to inpatient use 1
Prolonged use: Avoid extended courses; tramadol carries risk of persistent postpartum opioid use, with one study showing 30.9% of tramadol-exposed patients transitioning to persistent use (highest among all opioids studied) 5
Lack of monitoring: Never prescribe without establishing a clear monitoring plan for infant adverse effects
Ignoring alternatives: Given the availability of safer options (morphine, NSAIDs, paracetamol), tramadol should not be a first-line choice
Evidence Quality Note
While research data suggests relatively low infant exposure 3, the 2020 Association of Anaesthetists guideline takes a cautious stance based on case reports of serious adverse events, aligning with a harm-reduction approach that prioritizes infant safety 1. The discrepancy between FDA prohibition and UK cautious approval reflects ongoing uncertainty, making the restrictive inpatient-only recommendation the most prudent approach in real-world practice.